9 Meters Biopharma, Inc. (NMTR) Social Stream
9 METERS BIOPHARMA INC (NMTR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NMTR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-26 | 7 | $6 | $3 | $4.583 | $0.072 | 6265.28% |
| 2022-03-01 | 5 | $6 | $3 | $4.5 | $0.072 | 6150% |
| 2022-03-23 | 6 | $6 | $3 | $4.5 | $0.072 | 6150% |
| 2022-04-12 | 7 | $6 | $3 | $4.5 | $0.072 | 6150% |
| 2022-05-16 | 7 | $6 | $2 | $4.333 | $0.072 | 5918.06% |
| 2022-06-09 | 6 | $6 | $2 | $4.6 | $0.072 | 6288.89% |
| 2022-08-28 | 6 | $4 | $2 | $3.25 | $0.072 | 4413.89% |
| 2022-09-27 | 6 | $5 | $2 | $3.333 | $0.072 | 4529.17% |
| 2022-10-03 | 6 | $100 | $40 | $70.005 | $0.072 | 97129.17% |
| 2022-10-26 | 6 | $100 | $40 | $68.5 | $0.072 | 95038.89% |
| 2022-11-02 | 5 | $60 | $40 | $50.333 | $0.072 | 69806.94% |
| 2022-11-10 | 5 | $40 | $35 | $38 | $0.072 | 52677.78% |
| 2022-11-18 | 5 | $39 | $35 | $37.333 | $0.072 | 51751.39% |
| 2023-03-28 | 6 | $40 | $35 | $38 | $0.072 | 52677.78% |
| 2023-03-29 | 6 | $40 | $20 | $31.666 | $0.072 | 43880.56% |
| 2023-05-18 | 7 | $40 | $0.75 | $23.937 | $0.072 | 33145.83% |
The Trend in the Analyst Price Target
NMTR's average price target has moved up $14.62 over the prior 38 weeks.
NMTR reports an average of 3,874.13% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-27 | 6 | 5 | 2.00 | 3.500 | 0.214 | 1535.51% |
| 2022-10-03 | 6 | 5 | 2.00 | 3.500 | 0.232 | 1408.62% |
| 2023-05-18 | 4 | 35 | 0.75 | 17.875 | 0.800 | 2134.37% |
| 2023-05-18 | 2 | 40 | 0.75 | 23.937 | 0.800 | 2892.12% |
| 2023-05-18 | 6 | 35 | 0.75 | 18.583 | 0.800 | 2222.87% |
NMTR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 3 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
NMTR's average broker recommendation rating worsened by 0.8 over the prior 18 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- NMTR has a greater upside potential (average analyst target price relative to current price) than 2497.26% of all US stocks.
- In terms of how 9 METERS BIOPHARMA INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1660.93% of that group.
- NMTR has a higher average analyst price target than 1251.29% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, 9 METERS BIOPHARMA INC's number of analysts covering the stock is higher than 1686.85% of them.
In the Pharmaceutical Products industry, SYBX, ACRS, and WVE are the three stocks most similar to 9 METERS BIOPHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NMTR a Buy, Hold or Sell? See the POWR Ratings now!